SMTL ID : 7bk1.1

Crystal structure of CHK1-10pt-mutant complex with compound 32

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

1 x U0N: 4-amino-2-[(1,3-dimethyl-1H-pyrazol-4-yl)amino]-7-methyl-6-[(2R)-2-methylpyrrolidin-1-yl]-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile(Non-covalent)

U0N.1: 15 residues within 4Å: Chain A: L.15, G.16, E.17, G.18, V.23, A.36, I.68, E.85, L.86, A.87, G.90, H.134, N.135, L.137, A.147 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:V.23, A:V.23, A:L.86, A:L.137, A:A.147 Hydrogen bonds: A:E.85, A:A.87, A:A.87

2 x CL: CHLORIDE ION(Non-functional Binders)

CL.2: 1 residues within 4Å: Chain A: I.96 Ligand excluded by PLIP CL.3: 1 residues within 4Å: Chain A: K.261 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Williamson, D.S. et al., Design and Synthesis of Pyrrolo[2,3- d ]pyrimidine-Derived Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Checkpoint Kinase 1 (CHK1)-Derived Crystallographic Surrogate. J.Med.Chem. (2021)

Release Date

2021-07-07

Peptides

Serine/threonine-protein kinase Chk1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Serine/threonine-protein kinase Chk1

Related Entries With Identical Sequence